EXCERPT

> The world's leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines, with GlaxoSmithKline unveiling a new $43 million deal in the field on Sunday.
>
> Other pharmaceutical giants including Merck & Co, Johnson & Johnson and Sanofi are also exploring the potential of artificial intelligence (AI) to help streamline the drug discovery process.

Source: https://www.yahoo.com/news/big-pharma-turns-artificial-intelligence-speed-drug-discovery-025733105%2D%2Dfinance.html